Rocket scientist-turned-immunology expert Mark Kendall talks about his Nanopatch, which could revolutionise vaccinations and eradicate some diseases.

Mark Kendall (born 1972) is an Australian biomedical engineer and innovator. He is an Entrepreneurial Professor of the Australian National University. His field of research is the delivery of immunotherapeutics to the skin without the use of a needle or syringe.

In 2011, he co-founded the development company Vaxxas with an investor syndicate. The company’s technology, called Nanopatch, is intended to serve as a needle-free vaccine delivery device. In 2011, Kendall and his AIBN team received the Australian Research Council Eureka Prize for Excellence in Research by an Interdisciplinary Team. In 2012, he was awarded the Rolex Awards for Enterprise for his “pioneering efforts to expand knowledge and improve human life”.

Website